Palbociclib

Palbociclib is a small molecule which can act as a CDK4 / CDK6 inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Autophagy, Glycation, Cell cycle, Senescence, Carbohydrate metabolism.
This product may be of interest in the following research areas and diseases: Immunology, Cell death, Cancer, Diabetes.
This product may act as a Coronavirus inhibitor: Inhibits SARS-CoV in silico, probably through blocking the main protease, Mpro (3CLpro, Nsp5).

Please note that our chemical products are for scientific research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.

Solubility: 2 mg/ml in warm DMSO.

Target	Palbociclib
Form	Solid
Purity	> 98% (TLC). Conforms to structure by NMR.
Reconstitution	Soluble in DMSO (up to 2 mg/ml with warming)
Storage	Store desiccated at -20 °C for up to 2 years. Solutions can be stored at -20 °C for up to 1 month.
Molecular Weight	447.5 g/mol
Molecular Formula	C24H29N7O2
Buffer	Not applicable.
CAS Number	571190-30-2
Availability	Shipped within 5-10 working days.
Note	THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Research Articles on Palbociclib

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue